Difference between revisions of "Team:NTU-LIHPAO-Taiwan/Parts"

(Prototype team page)
 
Line 1: Line 1:
{{NTU-LIHPAO-Taiwan}}
 
 
<html>
 
<html>
 +
<head>
  
<h2> Part Documentation</h2>
+
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.6.2/jquery.min.js"></script>
  
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
<script type="text/javascript" charset="utf-8">
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
  
 +
//-----Hover Facebook Icon-----//
 +
$(document).ready(function(){
 +
$('#Facebook_icon_hover').hover(function () {
 +
this.src = "https://static.igem.org/mediawiki/2015/3/35/NTU-Top-Facebook_icon2.png";
 +
}, function () {
 +
this.src = "https://static.igem.org/mediawiki/2015/9/98/NTU-Top-Facebook_icon1.png";
 +
});
 +
});
  
<div class="highlightBox">
+
//-----Hover iGem Icon-----//
<h4>Note</h4>
+
$(document).ready(function(){
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
$('#iGEM_icon_hover').hover(function () {
</div>
+
this.src = "https://static.igem.org/mediawiki/2015/0/0a/NTU-Top-iGEM_icon2.png";
 +
}, function () {
 +
this.src = "https://static.igem.org/mediawiki/2015/1/1d/NTU-Top-iGEM_icon1.png";
 +
});
 +
});
  
 +
//-----Hover NTU Icon-----//
 +
$(document).ready(function(){
 +
$('#NTU_icon_hover').hover(function () {
 +
this.src = "https://static.igem.org/mediawiki/2015/6/6e/NTU-Top-NTU_icon2.png";
 +
}, function () {
 +
this.src = "https://static.igem.org/mediawiki/2015/1/14/NTU-Top-NTU_icon1.png";
 +
});
 +
});
  
 +
</script>
  
<h4>Adding parts to the registry</h4>
+
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
<title>NTU-LIHPAO-Taiwan</title>
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
<style type="text/css">
  
 +
/*-------------------------------------------*/
 +
/*--------------Wiki Page Reset--------------*/
 +
/*-------------------------------------------*/
  
<h4>What information do I need to start putting my parts on the Registry?</h4>
+
#contentSub, #contentcontainer, #footer-box, #sitesub, #catlinks, #search-controls, #p-logo, .h3, .printfooter, .firstHeading, .visualClear {
<p>The information needed to initially create a part on the Registry is:</p>
+
display: none;
<ul>
+
}
<li>Part Name</li>
+
<li>Part type</li>
+
<li>Creator</li>
+
<li>Sequence</li>
+
<li>Short Description (60 characters on what the DNA does)</li>
+
<li>Long Description (Longer description of what the DNA does)</li>
+
<li>Design considerations</li>
+
</ul>
+
  
<p>
+
#globalWrapper, #content {
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
+
width: 100%;
 +
height: 100%;
 +
border: 0px;
 +
background-color: transparent;
 +
margin: 0px;
 +
padding: 0px;
 +
}
  
 +
html, body, .wrapper {
 +
width: 100%;
 +
height: 100%;
 +
background-color: transparent;
 +
}
  
 +
/*-------------------------------------------*/
 +
/*-------------------Body--------------------*/
 +
/*-------------------------------------------*/
  
 +
body {
 +
background-color: #F0F0F0;
 +
}
 +
body,td,th {
 +
font-size: 14px;
 +
font-family: Calibri, "Arial Narrow", "Agency FB", "Raavi";
 +
}
 +
#Wrapper {
 +
margin-right: auto;
 +
margin-left: auto;
 +
background-color: #FFF;
 +
margin-top: 0px;
 +
margin-bottom: 0px;
 +
width: 90%;
 +
height: 10000px;
 +
top: 0px;
 +
left: 5%;
 +
right: 5%;
 +
position: absolute;
 +
bottom: 0px;
 +
padding-top: 0px;
 +
padding-bottom: 0px;
 +
z-index: 0;
 +
}
  
 +
#Wrapper_TopPic {
 +
margin-right: auto;
 +
margin-left: auto;
 +
background-color: #FFF;
 +
margin-top: 0px;
 +
margin-bottom: 0px;
 +
width: 100%;
 +
height: 58px;
 +
top: 0px;
 +
left:0px;
 +
right:0px;
 +
position: fixed;
 +
bottom: 0px;
 +
padding-top: 0px;
 +
padding-bottom: 0px;
 +
z-index: 9998;
 +
border-bottom-style: solid;
 +
border-bottom-color: #fe5838;
 +
border-bottom-width: 2px;
 +
z-index: 9998;
 +
background-repeat: no-repeat;
 +
}
  
 +
/*-------------------------------------------*/
 +
/*-----------------Top icons-----------------*/
 +
/*-------------------------------------------*/
 +
#Facebook_icon_pic {
 +
height: 30px;
 +
width: 30px;
 +
position: absolute;
 +
left: auto;
 +
top: 23px;
 +
right: 5.5%;
 +
bottom: auto;
 +
z-index: 9999;
 +
}
  
<h4>Inspiration</h4>
+
#iGEM_icon_pic {
<p>We have a created  a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
+
height: 30px;
 +
width: 38px;
 +
position: absolute;
 +
left: auto;
 +
top: 23px;
 +
right: 1%;
 +
bottom: auto;
 +
z-index: 9999;
 +
}
  
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
+
#NTU_icon_pic {
<ul>
+
height: 30px;
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
+
width: 69px;
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
+
position: absolute;
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
+
left: auto;
</ul>
+
top: 23px;
 +
right: 9%;
 +
bottom: auto;
 +
z-index: 9999;
 +
}
  
 +
#NTUXLIHPAO_icon {
 +
height: 40px;
 +
width: 200px;
 +
position: absolute;
 +
left: 3%;
 +
top: 18px;
 +
right: auto;
 +
bottom: auto;
 +
z-index: 9999;
 +
}
  
  
<h4>Part Table </h4>
 
</html>
 
<groupparts>iGEM015 Example</groupparts>
 
<html>
 
  
 +
/*-------------------------------------------*/
 +
/*-----------------Slide Menu----------------*/
 +
/*-------------------------------------------*/
 +
.Slidemenu {
 +
z-index: 9999;
 +
position: fixed;
 +
top: 32px;
 +
left: auto;
 +
right: 15%;
 +
list-style:none;
 +
margin:0;
 +
padding:0;
 +
/*background:rgba(100%,100%,100%,0); 主選單色系選擇*/
 +
}
  
 +
.Slidemenu ul {
 +
*zoom:1;
 +
list-style:none;
 +
margin:0;
 +
padding:0;
 +
/*background:rgba(100%,100%,100%,0); 主選單色系選擇*/
 +
}
  
 +
.Slidemenu ul:before,.Slidemenu ul:after {
 +
content:"";
 +
display:table;
 +
}
 +
 +
.Slidemenu ul:after {
 +
clear:both;
 +
}
 +
 +
.Slidemenu a {
 +
text-decoration:none;
 +
display:block;
 +
padding:4px 4px;
 +
line-height:1em;
 +
color:#000;
 +
text-align: center;
 +
vertical-align: middle;
 +
height: auto;
 +
width: auto;
 +
font-family: "Agency FB";
 +
font-size: 18px;
 +
}
 +
 +
.Slidemenu a:hover {
 +
text-decoration:none;
 +
background:rgba(0,0,0,0.03);
 +
text-align: center;
 +
vertical-align: middle;
 +
}
 +
 +
.Slidemenu li ul {
 +
position:absolute;
 +
left:0;
 +
top:26px;
 +
z-index:1;
 +
}
 +
 +
.Slidemenu li ul li {
 +
overflow:hidden;
 +
height:0;
 +
}
 +
 +
.Slidemenu li ul a {
 +
border:none;
 +
-webkit-transition:background 300ms ease-in-out;
 +
-moz-transition:background 300ms ease-in-out;
 +
-o-transition:background 300ms ease-in-out;
 +
transition:background 300ms ease-in-out;
 +
}
 +
 +
.Slidemenu li ul a:hover {
 +
background-color: rgba(240,240,240,1);
 +
}
 +
 +
.Slidemenu ul > li {
 +
text-decoration:none;
 +
float:left;
 +
position:relative;
 +
height: 27px; /*--改主要選單高度--*/
 +
width: 110px; /*--改主要選單寬度--*/
 +
}
 +
 +
.Slidemenu ul > li:hover ul.subs {
 +
height: auto;
 +
width: 150px; /*--改拉出的選單寬度--*/
 +
border-left-width: 3px;
 +
border-left-style: solid;
 +
border-left-color: #3300FF;
 +
background:rgba(255,255,255,1); /*--改拉出選單顏色--*/
 +
}
 +
 +
.Slidemenu ul > li:hover ul li {
 +
text-decoration:none;
 +
height: 24px; /*--改拉出的選單高度--*/
 +
width: 150px; /*--改拉出的選單寬度--*/
 +
text-align: center;
 +
vertical-align: middle;
 +
-webkit-transition:height 250ms ease-in;
 +
-moz-transition:height 250ms ease-in;
 +
-o-transition:height 250ms ease-in;
 +
transition:height 250ms ease-in;
 +
}
 +
 +
#Position_Now {
 +
background:rgba(0,0,0,0.03);
 +
}
 +
 +
 +
/*-------------------------------------------*/
 +
/*------------------Content------------------*/
 +
/*-------------------------------------------*/
 +
 +
#Content * {
 +
list-style: none;
 +
}
 +
 +
#Content {
 +
position: fixed;
 +
top: 0;
 +
left: 5.2%;
 +
width: 17.8%;
 +
height: 100%;
 +
padding: 0;
 +
margin: 0;
 +
background: #f7fbff;
 +
transition: 0.5s;
 +
font-size: 0.8rem;
 +
z-index: 5;
 +
font-family: Calibri;
 +
}
 +
 +
#Content-title {
 +
position: absolute;
 +
width: 100%;
 +
top: 0.5rem;
 +
font-size: 1.5rem;
 +
text-align: center;
 +
}
 +
 +
#Content ul {
 +
margin: 0.5rem 0rem 0.5rem;
 +
}
 +
 +
.main-Content {
 +
position: absolute;
 +
top: 5rem;
 +
left: 2rem;
 +
}
 +
 +
.main-Content #title {
 +
color: #ABCDEF;
 +
}
 +
 +
.main-Content > li {
 +
cursor: pointer;
 +
color: #369CF5;
 +
font-size: 25px;
 +
padding-top: 5px;
 +
padding-bottom: 5px;
 +
}
 +
 +
.sub-Content {
 +
font-size: 18px;
 +
overflow-y: auto;
 +
transition: 0.5s;
 +
padding-left: 2rem;
 +
}
 +
 +
.sub-Content > li {
 +
padding-top: 8px;
 +
padding-bottom: 8px;
 +
}
 +
 +
.sub-Content > li a{
 +
display: block;
 +
color: #0791DB;
 +
text-decoration: none;
 +
transition: 0.5s;
 +
}
 +
 +
.sub-Content > li a:hover {
 +
opacity: 0.5;
 +
}
 +
 +
/*-------------------------------------------*/
 +
/*-----------------Articles------------------*/
 +
/*-------------------------------------------*/
 +
 +
#Articles {
 +
width: 76%;
 +
height: 10000px;
 +
left: 22%;
 +
right: 2%;
 +
top: -10px;
 +
position: absolute;
 +
background-color: #FFF;
 +
z-index: 0;
 +
color: #000;
 +
}
 +
 +
.ContentBox {
 +
width: 100%;
 +
height: 675px;
 +
}
 +
 +
.Text1 {
 +
font-size: 36px;
 +
font-family: Calibri;
 +
left: 20px;
 +
right: 20px;
 +
padding-top: 80px;
 +
padding-right: 20px;
 +
padding-bottom: 10px;
 +
padding-left: 20px;
 +
border-bottom-width: 1px;
 +
border-bottom-style: solid;
 +
border-bottom-color: #000;
 +
}
 +
 +
.Text2 {
 +
font-size: 28px;
 +
font-family: Calibri;
 +
padding-top: 30px;
 +
padding-right: 50px;
 +
padding-bottom: 10px;
 +
padding-left: 50px;
 +
}
 +
 +
.Text3 {
 +
font-size: 20px;
 +
font-family: Calibri;
 +
text-align: justify;
 +
padding-top: 10px;
 +
padding-right: 80px;
 +
padding-bottom: 10px;
 +
padding-left: 80px;
 +
line-height: 26px;
 +
}
 +
 +
.Text_underline {
 +
text-decoration: underline;
 +
}
 +
 +
.Text_italic {
 +
font-style: italic;
 +
}
 +
 +
</style>
 +
</head>
 +
 +
 +
<!---------------------------------------->
 +
<!---------------------------------------->
 +
<!------------------BODY------------------>
 +
<!---------------------------------------->
 +
<!---------------------------------------->
 +
 +
<body>
 +
 +
<div id="Wrapper">
 +
<div id="Wrapper_TopPic">
 +
<div id="NTUXLIHPAO_icon"><img src="https://static.igem.org/mediawiki/2015/c/c7/NTU-Top-NTUXLIHPAO.png"  height="40" /></div>
 +
<div id="Facebook_icon_pic">
 +
<a href="https://www.facebook.com/NationalTaiwanUniversityiGEM"><img id="Facebook_icon_hover" src="https://static.igem.org/mediawiki/2015/9/98/NTU-Top-Facebook_icon1.png" /></a></div>
 +
<div id="iGEM_icon_pic">
 +
<a href="https://igem.org/Main_Page"><img id="iGEM_icon_hover" src="https://static.igem.org/mediawiki/2015/1/1d/NTU-Top-iGEM_icon1.png" /></a></div>
 +
<div id="NTU_icon_pic">
 +
<a href="http://www.ntu.edu.tw/english/index.html"><img id="NTU_icon_hover" src="https://static.igem.org/mediawiki/2015/1/14/NTU-Top-NTU_icon1.png" /></a></div>
 +
 +
<div class="Slidemenu">
 +
<ul>
 +
<li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan">Home</a>
 +
        </li>
 +
       
 +
<li><a href="#">Team</a>
 +
<ul class="subs">
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
</ul>
 +
        </li>
 +
       
 +
<li id=Position_Now><a>Project</a>
 +
<ul class="subs">
 +
<li><a href="#">Abstract</a></li>
 +
<li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Overview">Overview</a></li>
 +
<li><a href="#">Parts</a></li>
 +
</ul>
 +
</li>
 +
       
 +
<li><a href="#">Results</a>
 +
<ul class="subs">
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
</ul>
 +
</li>
 +
               
 +
<li><a href="#">Modeling</a>
 +
<ul class="subs">
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
</ul>
 +
</li>
 +
       
 +
<li><a href="#">Notebook</a>
 +
<ul class="subs">
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
</ul>
 +
</li>
 +
       
 +
<li><a href="#">Safety</a>
 +
<ul class="subs">
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
</ul>
 +
</li>
 +
 +
<li><a href="#">Human Practice</a>
 +
<ul class="subs">
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
<li><a href="#">Sub Item</a></li>
 +
</ul>
 +
</li>
 +
</ul>
 +
</div>
 +
</div>
 +
   
 +
<div id="Content">
 +
<ul class="main-Content">
 +
<li>
 +
<span class="title">Overview</span>
 +
<ul class="sub-Content">
 +
<li><a href="#First1">Pigout / Stay in Shape</a></li>
 +
</ul>
 +
</li>
 +
<li>
 +
<span class="title">Background</span>
 +
<ul class="sub-Content">
 +
<li><a href="#Second1">CPP-PYY</a></li>
 +
<li><a href="#Second2">Nisin Selection</a></li>
 +
<li><a href="#Second3">Suicide</a></li>
 +
</ul>
 +
</li>
 +
<li>
 +
<span class="title">Design</span>
 +
<ul class="sub-Content">
 +
<li><a href="#Third1">CPP-PYY</a></li>
 +
<li><a href="#Third2">Nisin Selection</a></li>
 +
<li><a href="#Third3">Suicide</a></li>
 +
</ul>
 +
</li>
 +
<li>
 +
<span class="title">Result</span>
 +
<ul class="sub-Content">
 +
<li><a href="#Fourth1">CPP-PYY</a></li>
 +
<li><a href="#Fourth2">Nisin Selection</a></li>
 +
<li><a href="#Fourth3">Suicide</a></li>
 +
</ul>
 +
</li>
 +
</ul>
 +
</div>
 +
<script>
 +
(function() {
 +
var main_Contents = document.querySelectorAll("ul.main-Content>li");
 +
function ContentOpen(index) {
 +
for (var i = 0; i < main_Contents.length; i++) {
 +
var sub_Content = main_Contents[i].querySelector(".sub-Content");
 +
if (i === index) {
 +
sub_Content.style.height = '12rem';
 +
} else {
 +
sub_Content.style.height = '0';
 +
}
 +
}
 +
}
 +
function makeContentOpenFunc(index) {
 +
return function() {
 +
ContentOpen(index);
 +
};
 +
}
 +
for (var i = 0; i < main_Contents.length; i++) {
 +
main_Contents[i].onclick = makeContentOpenFunc(i);
 +
}
 +
ContentOpen(0);
 +
})();
 +
</script>
 +
 +
<div class="Text_italic"><i>Lactobacillus casei</i></div>
 +
<div id="Articles">
 +
<div class="ContentBox">
 +
<div class="ContentHolder">
 +
<div class="Text1">Overview</div>
 +
<div class="Text2" id="First1">Pigout Versus Stay in Shape</div>
 +
<div class="Text3">
 +
This year, iGEM team of NTU-LIHPAO-Taiwan take note of the problem that the obesity condition in Taiwan has deteriorated. Moreover, the market is flooded with those unverified slimming drugs that harm the public health simultaneously. Therefore, we hope to initiate our project from the key peptide “Peptide YY (PYY)” which can control appetite, and take advantage of the probiotic characteristic of <i>Lactobacillus casei</i>, with cell penetrating peptides which contain large developmental potential in oral peptide drugs. We hope that we can make <i>Lactobacillus casei</i> secret CPP-PYY complex which can be another newly created oral peptide drugs.
 +
</div>
 +
<div class="Text1">Background</div>
 +
<div class="Text2" id="Second1">CPP-PYY</div>
 +
<div class="Text3"><div class="Text_underline">Cell Penetrating Peptide (CPP)</div></div>
 +
<div class="Text3">
 +
CPP is a kind of short segment peptide that can spontaneously carry macromolecules such as DNA, proteins, and peptides to penetrate cell membrane. Generally speaking, they often contain less than 40 amino acids and also called protein transduction domain (PTDs) or membrane transduction domain (MTDs). CPP which is first discovered and extensively studied is TAT protein derived from human immunodeficiency virus-1 (HIV-1) and antennapedia homeodomain (Antp) transcription factor comes from Drosophila melanogaster. The shortest segments diagnosed from the sequences are TAT and penetratin, and more and more CPPs come into existence from the following studies. There are also synthetic amino acid sequences such as R9.
 +
</div>
 +
<div class="Text3">
 +
However, the mechanism of CPP penetrating cell membrane is still vague, and different CPPs, CPP-cargo complexes, secondary structures have significant effect on distinct cells’ penetrating mechanism. Currently, there are majorly two pathways: energy-independent direct penetration and energy-consuming endocytosis, and two pathways both have three same steps: membrane interaction, membrane permeation, secreting CPPs to cytoplasm.
 +
Direct penetration, first of all, positively charged CPPs draw negatively charged molecules on membrane such as HS, phospholipid dilayer, with integral proteins folded causing membrane temporarily collapse making CPP penetrate cell membrane, and it may form an inverted micelle or a pore. It increases partial hydrogen concentration that CPPs enter the cytoplasm, forming the concentration gradient, it makes CPPs move from one side to the other, and whether TAT penetrate the cell depends on the concentration and cargo’s properties.
 +
</div>
 +
<div class="Text3">
 +
Endocytosis uses pinocytosis, macropinocytosis, receptor-mediated endocytosis to form vesicles, transporting CPPs into cytoplasm. Because in the early phase scientists recognized that CPP can penetrate cell membrane in 4oC so that they deducted CPP majorly penetrate cell membrane with direct penetration. Nonetheless, current studies show that endocytosis more or less involves in the penetrating process of different CPPs in various conditions.
 +
</div>
 +
<div class="Text3"><div class="Text_underline">Peptide YY (PYY)</div></div>
 +
<div class="Text3">
 +
Peptide YY is a short peptide that can restrain our appetite. Because the peptide’s head and tail are both amino acid, tyrosine (Y), it is named peptide YY (PYY). PYY has two forms: PYY 1-36 is the unmodified form, and PYY 3-36 is the kind of PYY cut off two amino acids in N-terminal side by dipeptidyl peptidase-IV. Each contains 60% and 40% of all PYY.
 +
</div>
 +
<div class="Text3">
 +
In the situation of PYY binding to the receptors, PYY 1-36’s affinity to Y1, Y2, Y4,and Y5 are all high. However, because PYY 3-36 is cut off two amino acids in N-terminal side causing conformational change, its affinity to Y2 is higher than others. Since both two types of PYY don’t require disulfide bond to stable its structure, it can spontaneously become a stable and activated form in the solution.
 +
PYY is classified as gastrointestinal(GI) hormone. After intestine absorbs micromolecule nutrients, ileum and colon epithelial cells will secret PYY to blood. As PYY contact hypothalamus by blood circulation.
 +
</div>
 +
 +
<div class="Text2" id="Second2">Nisin Selection</div>
 +
<div class="Text3"><div class="Text_underline">Lactic Acid Bacteria (LAB)</div></div>
 +
<div class="Text3">
 +
In our project, we choose <i>Lactobacillus casei</i> ATCC393 as the study material which belongs to the diverse family of lactic acid bacteria. Lactic acid bacteria are not a formal term in taxonomy; as a matter of fact, the lactic acid bacteria are referred to as a group of microorganism that are able to metabolite carbohydrates to produce lactic acid with the yield over 50%. [1] One notable fact is that lactic acid bacteria are long be used in the manufacture of dairy products, and therefore they are generally regarded as safe (GRAS). Moreover, they are the most representative probiotics in the intestines.
 +
</div>
 +
<div class="Text3"><div class="Text_underline">Nisin</div></div>
 +
<div class="Text3">
 +
Since we are aim to produce PYY for the further use in human beings, a food-grade experimental procedure must be conducted. Here we choose nisin, a kind of bacteriocins excreted by <i>Lactococcus lactis</i>, as our selection marker. Bacteriocins are antimicrobial peptides produced by bacteria to kill or inhibit the growth of similar or closely related bacterial strain(s). [2] For nisin, however, it can form pores in the bacterial cytoplasmic membrane and decrease the membrane potential; thus, it has a broader range of target cells. [3] Nisin-producing organisms have their specific way to protect their cell membrane from the nisin pore-forming activity. We use this characteristic of nisin immunity to select cells containing out target plasmids. The detailed self-protection mechanism is discussed in the Design section.
 +
</div>
 +
               
 +
<div class="Text2" id="Second3">Suicide</div>
 +
<div class="Text3"><div class="Text_underline">Programmed Cell Death</div></div>
 +
<div class="Text3">
 +
The prototype of our product is an oral capsule which can function well while it reaches the human intestines. Although <i>Lactobacillus casei</i> ATCC393 as a probiotic would not do harm to the consumers’ healthy, for safety concern, cell apoptosis should be introduced due to several reasons. To begin with, we want to control the quantity of PYY within a proper range so as not to cause side-effects. What we value the most is the yield of PYY produced by the time the cell died; therefore, the concentration of bacteria being put into the capsule can be determined with its penetration rate taken into consideration. Another critical reason is that the genes transfer among bacteria and with the environment must be diminished. Otherwise, it may not only interfere the gut flora, but also contaminate the surroundings. With those concerns, we found a desirable part in the iGEM biobricks, namely NcuA. [4] It is a thermonuclease that degrades both plasmid and chromosomal DNA. For more information, please go to the Design section.
 +
</div>
 +
 +
<div class="Text1">Design</div>
 +
<div class="Text2" id="Third1">CPP-PYY</div>
 +
<div class="Text2" id="Third2">Nisin Selection</div>
 +
<div class="Text3">(Fig. Promoter-RBS-nisI-Ter)</div>
 +
<div class="Text3">
 +
Studies have showed that for nisin resistance, the immunity lipoprotein NisI as well as the ABC transporter-homologous system NisF/E/G is involved. Functional analysis suggests that NisI acts as nisin-intercepting protein, while NisF/E/G complex acts as exporter that expels the unwanted nisin molecules from cytoplasm to the outer environment. [4] Researchers find that NisI seems to play a more crucial role in nisin immunity than the NisF/E/G complex. [5] Through experiments, either of each expressing in the heterologous bacteria is able to protect the host cells.
 +
</div>
 +
<div class="Text2" id="Third3">Suicide</div>
 +
<div class="Text1">Result</div>
 +
<div class="Text2" id="Fourth1">CPP-PYY</div>
 +
<div class="Text2" id="Fourth2">Nisin Selection</div>
 +
<div class="Text3">(Fig. Promoter-RBS-nisI-Ter)</div>
 +
<div class="Text3">(Fig. plasmid)</div>
 +
<div class="Text3">
 +
Studies have showed that for nisin resistance, the immunity lipoprotein NisI as well as the ABC transporter-homologous system NisF/E/G is involved. Functional analysis suggests that NisI acts as nisin-intercepting protein, while NisF/E/G complex acts as exporter that expels the unwanted nisin molecules from cytoplasm to the outer environment. [5] Researchers find that NisI seems to play a more crucial role in nisin immunity than the NisF/E/G complex. [6] Through experiments, either of each expressing in the heterologous bacteria is able to protect the host cells. [5] Moreover, the expression of nisI in <i>Lactobacillus plantarum</i> was assessed to be at the same level as in <i>Lactococcus lactis</i>. [6]
 +
</div>
 +
<div class="Text3">
 +
The figure above shows our gene circuit for nisin selection. The promoter we chose was pUO19 from <i>Escherichia coli</i> which is also functional in <i>Lactobacillus casei</i> and the gene <i>nisI</i> helps <i>Lactobacillus casei</i> transform from nisin-sensitive into nisin-resistant. The fraction enlarged was latter proceeded ligation with CPP-PYY circuit, enabling the following selection.
 +
</div>
 +
 +
<div class="Text2" id="Fourth3">Suicide</div>
 +
<div class="Text3">(Fig. plac-RBS-RFP-Ter)</div>
 +
<div class="Text3">(Fig. plac-RBS-CI-Ter)</div>
 +
<div class="Text3">(Fig. pCI-RBS-NcuA-Ter)</div>
 +
 +
</div>
 +
</div>
 +
</div>
 +
 +
<script>
 +
$('.sub-Content>li a').click(function() {
 +
console.log(this.hash);
 +
if (location.pathname.replace(/^\//,'') == this.pathname.replace(/^\//,'') || location.hostname == this.hostname) {
 +
var target = $('[id="'+this.hash.substring(1)+'"]');
 +
target = target.length ? target : $('[name="' + this.hash.slice(1) +'"]');
 +
if (target.length) {
 +
$('html,body').animate({
 +
scrollTop: target.offset().top-55
 +
}, 700);
 +
return false;
 +
}
 +
}
 +
});
 +
 +
$('.title').click(function() {
 +
console.log(this.hash);
 +
if (location.pathname.replace(/^\//,'') == this.pathname.replace(/^\//,'') || location.hostname == this.hostname) {
 +
var target = $('[id="'+this.hash.substring(1)+'"]');
 +
target = target.length ? target : $('[name="' + this.hash.slice(1) +'"]');
 +
if (target.length) {
 +
$('html,body').animate({
 +
scrollTop: target.offset().top-55
 +
}, 700);
 +
return false;
 +
}
 +
}
 +
});
 +
</script>
 
</div>
 
</div>
 +
 +
</body>
 
</html>
 
</html>

Revision as of 10:51, 14 August 2015

NTU-LIHPAO-Taiwan

Lactobacillus casei
Overview
Pigout Versus Stay in Shape
This year, iGEM team of NTU-LIHPAO-Taiwan take note of the problem that the obesity condition in Taiwan has deteriorated. Moreover, the market is flooded with those unverified slimming drugs that harm the public health simultaneously. Therefore, we hope to initiate our project from the key peptide “Peptide YY (PYY)” which can control appetite, and take advantage of the probiotic characteristic of Lactobacillus casei, with cell penetrating peptides which contain large developmental potential in oral peptide drugs. We hope that we can make Lactobacillus casei secret CPP-PYY complex which can be another newly created oral peptide drugs.
Background
CPP-PYY
Cell Penetrating Peptide (CPP)
CPP is a kind of short segment peptide that can spontaneously carry macromolecules such as DNA, proteins, and peptides to penetrate cell membrane. Generally speaking, they often contain less than 40 amino acids and also called protein transduction domain (PTDs) or membrane transduction domain (MTDs). CPP which is first discovered and extensively studied is TAT protein derived from human immunodeficiency virus-1 (HIV-1) and antennapedia homeodomain (Antp) transcription factor comes from Drosophila melanogaster. The shortest segments diagnosed from the sequences are TAT and penetratin, and more and more CPPs come into existence from the following studies. There are also synthetic amino acid sequences such as R9.
However, the mechanism of CPP penetrating cell membrane is still vague, and different CPPs, CPP-cargo complexes, secondary structures have significant effect on distinct cells’ penetrating mechanism. Currently, there are majorly two pathways: energy-independent direct penetration and energy-consuming endocytosis, and two pathways both have three same steps: membrane interaction, membrane permeation, secreting CPPs to cytoplasm. Direct penetration, first of all, positively charged CPPs draw negatively charged molecules on membrane such as HS, phospholipid dilayer, with integral proteins folded causing membrane temporarily collapse making CPP penetrate cell membrane, and it may form an inverted micelle or a pore. It increases partial hydrogen concentration that CPPs enter the cytoplasm, forming the concentration gradient, it makes CPPs move from one side to the other, and whether TAT penetrate the cell depends on the concentration and cargo’s properties.
Endocytosis uses pinocytosis, macropinocytosis, receptor-mediated endocytosis to form vesicles, transporting CPPs into cytoplasm. Because in the early phase scientists recognized that CPP can penetrate cell membrane in 4oC so that they deducted CPP majorly penetrate cell membrane with direct penetration. Nonetheless, current studies show that endocytosis more or less involves in the penetrating process of different CPPs in various conditions.
Peptide YY (PYY)
Peptide YY is a short peptide that can restrain our appetite. Because the peptide’s head and tail are both amino acid, tyrosine (Y), it is named peptide YY (PYY). PYY has two forms: PYY 1-36 is the unmodified form, and PYY 3-36 is the kind of PYY cut off two amino acids in N-terminal side by dipeptidyl peptidase-IV. Each contains 60% and 40% of all PYY.
In the situation of PYY binding to the receptors, PYY 1-36’s affinity to Y1, Y2, Y4,and Y5 are all high. However, because PYY 3-36 is cut off two amino acids in N-terminal side causing conformational change, its affinity to Y2 is higher than others. Since both two types of PYY don’t require disulfide bond to stable its structure, it can spontaneously become a stable and activated form in the solution. PYY is classified as gastrointestinal(GI) hormone. After intestine absorbs micromolecule nutrients, ileum and colon epithelial cells will secret PYY to blood. As PYY contact hypothalamus by blood circulation.
Nisin Selection
Lactic Acid Bacteria (LAB)
In our project, we choose Lactobacillus casei ATCC393 as the study material which belongs to the diverse family of lactic acid bacteria. Lactic acid bacteria are not a formal term in taxonomy; as a matter of fact, the lactic acid bacteria are referred to as a group of microorganism that are able to metabolite carbohydrates to produce lactic acid with the yield over 50%. [1] One notable fact is that lactic acid bacteria are long be used in the manufacture of dairy products, and therefore they are generally regarded as safe (GRAS). Moreover, they are the most representative probiotics in the intestines.
Nisin
Since we are aim to produce PYY for the further use in human beings, a food-grade experimental procedure must be conducted. Here we choose nisin, a kind of bacteriocins excreted by Lactococcus lactis, as our selection marker. Bacteriocins are antimicrobial peptides produced by bacteria to kill or inhibit the growth of similar or closely related bacterial strain(s). [2] For nisin, however, it can form pores in the bacterial cytoplasmic membrane and decrease the membrane potential; thus, it has a broader range of target cells. [3] Nisin-producing organisms have their specific way to protect their cell membrane from the nisin pore-forming activity. We use this characteristic of nisin immunity to select cells containing out target plasmids. The detailed self-protection mechanism is discussed in the Design section.
Suicide
Programmed Cell Death
The prototype of our product is an oral capsule which can function well while it reaches the human intestines. Although Lactobacillus casei ATCC393 as a probiotic would not do harm to the consumers’ healthy, for safety concern, cell apoptosis should be introduced due to several reasons. To begin with, we want to control the quantity of PYY within a proper range so as not to cause side-effects. What we value the most is the yield of PYY produced by the time the cell died; therefore, the concentration of bacteria being put into the capsule can be determined with its penetration rate taken into consideration. Another critical reason is that the genes transfer among bacteria and with the environment must be diminished. Otherwise, it may not only interfere the gut flora, but also contaminate the surroundings. With those concerns, we found a desirable part in the iGEM biobricks, namely NcuA. [4] It is a thermonuclease that degrades both plasmid and chromosomal DNA. For more information, please go to the Design section.
Design
CPP-PYY
Nisin Selection
(Fig. Promoter-RBS-nisI-Ter)
Studies have showed that for nisin resistance, the immunity lipoprotein NisI as well as the ABC transporter-homologous system NisF/E/G is involved. Functional analysis suggests that NisI acts as nisin-intercepting protein, while NisF/E/G complex acts as exporter that expels the unwanted nisin molecules from cytoplasm to the outer environment. [4] Researchers find that NisI seems to play a more crucial role in nisin immunity than the NisF/E/G complex. [5] Through experiments, either of each expressing in the heterologous bacteria is able to protect the host cells.
Suicide
Result
CPP-PYY
Nisin Selection
(Fig. Promoter-RBS-nisI-Ter)
(Fig. plasmid)
Studies have showed that for nisin resistance, the immunity lipoprotein NisI as well as the ABC transporter-homologous system NisF/E/G is involved. Functional analysis suggests that NisI acts as nisin-intercepting protein, while NisF/E/G complex acts as exporter that expels the unwanted nisin molecules from cytoplasm to the outer environment. [5] Researchers find that NisI seems to play a more crucial role in nisin immunity than the NisF/E/G complex. [6] Through experiments, either of each expressing in the heterologous bacteria is able to protect the host cells. [5] Moreover, the expression of nisI in Lactobacillus plantarum was assessed to be at the same level as in Lactococcus lactis. [6]
The figure above shows our gene circuit for nisin selection. The promoter we chose was pUO19 from Escherichia coli which is also functional in Lactobacillus casei and the gene nisI helps Lactobacillus casei transform from nisin-sensitive into nisin-resistant. The fraction enlarged was latter proceeded ligation with CPP-PYY circuit, enabling the following selection.
Suicide
(Fig. plac-RBS-RFP-Ter)
(Fig. plac-RBS-CI-Ter)
(Fig. pCI-RBS-NcuA-Ter)